Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-25-009116

Director gave up 33,750 shares (to pay taxes)

  • Director acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WEINSTEIN ROBERT Director 2025-12-12 Grant or award +75,000 75,000 D: show line 1 in the form
WEINSTEIN ROBERT Director 2025-12-12 Shares withheld for taxes −33,750 $1.02 $34,425 41,250 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
WEINSTEIN ROBERT Director 2025-04-25 Grant or award · Stock Option (Right to Buy) +63,233 63,233 D: show line 3 in the form
Loading xslF345X05/ownership.xml…